A detailed history of Vanguard Group Inc transactions in 908 Devices Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,751,102 shares of MASS stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,751,102
Previous 1,744,330 0.39%
Holding current value
$10.2 Million
Previous $19.6 Million 32.45%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$6.55 - $9.92 $44,356 - $67,178
6,772 Added 0.39%
1,751,102 $13.2 Million
Q4 2023

Feb 14, 2024

BUY
$4.96 - $12.41 $163,898 - $410,076
33,044 Added 1.93%
1,744,330 $19.6 Million
Q3 2023

Nov 14, 2023

SELL
$6.0 - $8.2 $110,028 - $150,371
-18,338 Reduced 1.06%
1,711,286 $11.4 Million
Q2 2023

Aug 14, 2023

BUY
$5.78 - $10.02 $1.34 Million - $2.33 Million
232,540 Added 15.53%
1,729,624 $11.9 Million
Q1 2023

May 15, 2023

SELL
$6.61 - $10.66 $3,714 - $5,990
-562 Reduced 0.04%
1,497,084 $12.9 Million
Q4 2022

Feb 10, 2023

BUY
$7.0 - $17.96 $528,465 - $1.36 Million
75,495 Added 5.31%
1,497,646 $11.4 Million
Q3 2022

Nov 14, 2022

BUY
$15.18 - $24.99 $4.39 Million - $7.22 Million
288,923 Added 25.5%
1,422,151 $23.4 Million
Q2 2022

Aug 12, 2022

BUY
$13.3 - $20.74 $3.22 Million - $5.02 Million
242,204 Added 27.18%
1,133,228 $23.3 Million
Q1 2022

May 13, 2022

BUY
$13.18 - $26.28 $696,418 - $1.39 Million
52,839 Added 6.3%
891,024 $16.9 Million
Q4 2021

Feb 14, 2022

BUY
$23.17 - $38.77 $4.35 Million - $7.28 Million
187,824 Added 28.88%
838,185 $21.7 Million
Q3 2021

Nov 12, 2021

BUY
$29.99 - $39.13 $7.06 Million - $9.21 Million
235,297 Added 56.69%
650,361 $21.2 Million
Q2 2021

Aug 13, 2021

BUY
$36.7 - $55.11 $15.2 Million - $22.9 Million
415,064 New
415,064 $16.1 Million

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $184M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.